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Membrane type 1-matrix metalloprotease (MT1-MMP or MMP-14) is a major activator of pro-MMP-2 and is essential for skeletal
development. We show here that it is required for branching morphogenesis of the submandibular gland but not the lung. Instead, in the lung,
it is essential for postnatal development of alveolar septae. Lung development in Mmp14/ mice is arrested at the prealveolar stage with
compensatory hyperinflation of immature saccules. Mmp2/ mice lacked comparable defects in the lung and submandibular gland,
suggesting that MT1-MMP acts via mechanisms independent of pro-MMP-2 activation. Since the developmental defects in the lung are first
manifest around the time of initial vascularization (E16.5), we investigated the behavior of pulmonary endothelial cells from Mmp14+/+ and
Mmp14/ mice. Endothelial cells from lungs of 1-week-old Mmp14/ mice show reduced migration and formation of three-dimensional
structures on Matrigel. Since pulmonary septal development requires capillary growth, the underlying mechanism of pulmonary hypoplasia
in Mmp14/ mice may be defective angiogenesis, supporting a model in which angiogenesis is a critical rate-limiting step for acquisition
of pulmonary parenchymal mass.
D 2004 Elsevier Inc. All rights reserved.
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The development of epithelial organs such as the lung,
submandibular gland, breast, liver, and kidney involves
complex interactions between epithelial and stromal cells,
the developing vasculature, and the surrounding extracel-0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: aptes@ccf.org (S.S. Apte).lular matrix (ECM) (Affolter et al., 2003; Kanwar et al.,
2004; Warburton et al., 2000). In this context, ECM and
ECM-degrading proteases provide major environmental
influences, affecting cell migration, proliferation, differ-
entiation, attachment, and apoptosis (Blavier and Delaisse,
1995; Giannelli et al., 1997; Simian et al., 2001; Werb,
1997). Typically, proteases are highly regulated by tran-
scriptional regulation, zymogen activation, cell/tissue com-
partmentalization, and secreted inhibitors, and they often
have restricted substrate specificity. For these reasons, it is
likely that individual proteases may be required at distinct277 (2005) 255–269
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processes in their morphogenesis. Historically, one of the
major classes of proteases in the developmental context are
matrix metalloproteases (MMPs), which constitute a large
family of Zn2+- and Ca2+-dependent enzymes (Somerville et
al., 2003; Werb, 1997). These proteases are synthesized as
zymogens, and following activation, they are regulated by
tissue inhibitors of metalloproteinases (TIMPs). MMPs have
been implicated in the development of epithelial organs by a
variety of experimental approaches. For instance, synthetic
and natural metalloprotease inhibitors have been shown to
influence developmental processes in vitro and in vivo
(Alexander et al., 1996; Ganser et al., 1991; Simian et al.,
2001; Wiseman et al., 2003). Such inhibitors typically
inhibit not just one, but a number of MMPs. Furthermore,
MMP inhibitors can affect a larger constituency of proteases
than is usually considered, such as metalloproteases of the
ADAM and ADAMTS families. Another approach, over-
expression of metalloproteases in transgenic mice, has
provided insight into what proteases can do (D’Armiento
et al., 1992; Sympson et al., 1994; Witty et al., 1995), but
not necessarily into what individual enzymes actually do in
vivo. Surprisingly, inactivation of individual MMP genes in
mice suggested that many MMPs have modest develop-
mental roles (Parks and Shapiro, 2001; Somerville et al.,
2003) since the null mice have not shown obvious
developmental defects. However, careful analysis is begin-
ning to uncover physiological functions using these genetic
models (Wiseman et al., 2003).
MMPs exist as both secreted and membrane-bound
forms. The membrane-type MMPs (MT-MMPs) are anch-
ored to the cell surface through a membrane-spanning
segment or a glycosylphospatidylinositol (GPI) anchor
(Yana and Seiki, 2002; Zucker et al., 2003). Membrane
type 1 (MT1)-MMP (or MMP-14)1, a type I transmembrane
protein (Sato et al., 1994), is the most extensively studied of
the six cell-surface MMPs. Mmp14 is subject to a high
degree of temporal and spatial transcriptional regulation
during development (Apte et al., 1997; Kinoh et al., 1996).
Transcriptional regulation is especially significant in the
case of MT1-MMP since, like the other MT-MMPs, its
prodomain is constitutively removed by proprotein con-
vertases (e.g., furin) in the secretory pathway, resulting in
delivery of catalytically active enzyme at the cell surface
(Sato et al., 1996; Yana and Weiss, 2000). Although it can
degrade molecules such as collagen I, laminin, fibrin, and
fibronectin (Hotary et al., 2002; Ohuchi et al., 1997), MT1-
MMP is better known as the cell-surface activator of pro-
MMP-2 (also known as progelatinase A) (Sato et al., 1994).
MMP-2 has long been thought to be an important protease
in the context of development. Mutations in human MMP-21 Since MT1-MMP is generally used in the literature to describe MMP-
14 protein, we have used this term throughout the paper. However, when
referring to the genes we have used the approved gene nomenclature, for
example, Mmp14 and Mmp2.cause a multicentric osteolysis and arthritis syndrome
(Martignetti et al., 2001). Unlike MT1-MMP, MMP-2 is
secreted as a zymogen, pro-MMP-2. The pro-MMP-2
activation process requires the formation of a trimolecular
complex in which TIMP-2 links MT1-MMP to MMP-2
(Sato et al., 1994; Strongin et al., 1995). Previous studies
describing coordinated developmental expression of
Mmp14, Mmp2, and Timp2 (Apte et al., 1997; Kinoh et
al., 1996) seemed to underscore the essential role of MT1-
MMP and TIMP-2 in pro-MMP-2 activation and suggesQ
ted that MMP-2 was critical for development. Neither
Mmp2/ nor Timp2/ mice, however, have major
developmental anomalies (Itoh et al., 1997; Wang et al.,
2000), while Mmp14/ mice have the most striking
developmental phenotype of all null MMP alleles. Their
phenotype consists of postnatal dwarfism, musculoskeletal
defects including reduced growth plate proliferation, and
defective vascular invasion of the skeleton. Mmp14/
mice usually die by 3 weeks of age of unknown causes
(Holmbeck et al., 1999; Zhou et al., 2000). MT1-MMP also
activates collagenase-2 or MMP-13 (Knauper et al., 2002),
which is primarily expressed in the developing skeleton in
mice and humans (Blavier and Delaisse, 1995; Johansson
et al., 1997).
Here, Mmp14/ mice are shown to have defects in the
lung and submandibular gland, suggesting an essential role
for MT1-MMP in development of these epithelial organs.
Lack of MT1-MMP substantially affects branching morpho-
genesis in vitro in the submandibular gland, but not in the
lung. Instead, in the lung, MT1-MMP has a major role in the
postnatal development of the alveolar septum, whose
function is to dramatically increase the pulmonary surface
area available for exchange of respiratory gases. Septal
extension requires capillary growth, and in addition to
defective angiogenesis previously noted in Mmp14/
mice, we specifically show here that lung endothelial cells
are defective in migration and fail to form three-dimensional
structures on a Matrigel substratum. We propose that failed
septation is a consequence of impaired angiogenesis in
Mmp14/ mice. Mmp2/ mice are shown not to have
comparable anomalies, suggesting that MT1-MMP acts in
these contexts via mechanism(s) independent of pro-MMP-2
activation.Materials and methods
Mmp14 and Mmp2 transgenic mice
Mice with inactivated Mmp14 (MT1-MMP) alleles have
been described previously (Zhou et al., 2000) and were
maintained in the C57/BL6 strain. Crosses of heterozygous
(+/) mice were established to produce Mmp14/ and
+/+ littermates of various embryonic and postnatal ages. The
morning of the day, a vaginal plug was detected was
designated as E0.5.Mmp2/ mice (C57/BL6) were kindly
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previously (Itoh et al., 1997). Genotyping of theMmp14 and
Mmp2 mouse strains was performed by PCR.
Routine histology, immunohistochemistry, in situ
hybridization, and three-dimensional histological
construction
Unless obtained from embryos, lungs were always
fixed under inflation by intratracheal infusion of fixative
as well as by immersion in the fixative. Tissues were
fixed in 10% formalin, 4% paraformaldehyde, or Histo-
choicek according to the specific application and
embedded in paraffin. Alternatively, tissue was also frozen
in OCT for cryosectioning. Sections (5–7 Am thick) were
stained with hematoxylin and eosin (H and E), the Movat
pentachrome stain, and modified Hart’s stain for elastin.
Immunohistochemistry utilized antibodies to elastin, von
Willebrand factor (vWF) (Dako), PECAM/CD31 (Phar-
mingen), surfactant protein B (Chemicon), Clara cell-
secreted protein (provided by Dr. Barry Stripp), and
smooth muscle a-actin (Dako). In situ hybridization of
digoxigenin or radioactive cRNA probes to cryosections
or paraffin sections, respectively, was done as previously
described (Albrecht et al., 1997). Surfactant protein C
(Spc) cRNA probes were radiolabeled prior to in situ
hybridization as previously described (Deterding and
Shannon, 1995). H and E stained sections were used to
determine the mean linear intercept in Mmp14/ and
Mmp14+/+ mice, and statistical analysis by t test for
paired data was done using a computer software package
(InStat, Graph Pad, San Diego, CA).
For three-dimensional reconstruction of the E18.5
bronchial tree, Mmp14/ and Mmp14+/+ littermate lungs
were inflation-fixed in 10% formalin. The periphery of the
lungs was then reconstructed from imaging 5-Am serial
sections using proprietary histological technology and
analytical software (Resolution Sciences, Corte Madera,
CA, now defunct). The prospective airspaces were con-
structed by ascribing a solid volume to all spaces that were
devoid of tissue. Subsequently, all stained tissue was
subtracted, leaving behind a bvirtual corrosion castQ of the
lung periphery. Desmosine analysis was performed on lung
hydrolysates as previously described (Starcher and Conrad,
1995).
Scanning (SEM) and transmission electron microscopy
(TEM)
Lungs from 2-week-old Mmp14/ and Mmp14+/+
littermate mice were fixed by intratracheal perfusion with
1.25% glutaraldehyde in PBS under inflation and immersed
further in the same fixative for 4 h, dehydrated, and
sputter-coated with gold at a rate of 3 A8/s (SPI-Module
Sputter Coater, SPI Supplies, Inc). Specimens for SEM
were viewed under a Jeol JSM-5310 scanning electronmicroscope. Specimens for TEM were fixed as for SEM,
washed with cold sodium cacodylate buffer (0.2 M, pH
7.3) three times for 5 min each, osmicated using 1%
osmium tetroxide in water for 1 h, and rinsed twice in
cacodylate buffer and maleate buffer, followed by staining
with 1% uranyl acetate. Specimens were dehydrated and
embedded in LX-112 medium. Thick (1 Am) sections were
prepared for light microscopy by staining with toluidine
blue, and thin sections (80 nm) were mounted on formvar-
coated grids for viewing under a Phillips electron micro-
scope at 80 kV.
In vitro organ culture
Lung rudiments dissected from E12.5 Mmp14/ and
+/+ embryos were cultured for 72 h on porous membranes
(8-Am pore size, Nucleopore, Whatman) in 24-well plates.
Cultures were maintained at 378C in 95% air, 5% CO2 in 1
ml of Dulbecco’s modified Eagle medium, nutrient mixture
F-12 (1:1, Gibco BRL) supplemented with 0.03 mM sodium
bicarbonate, 10 Ag/ml apo-transferrin, 1 Ag/ml BSA, and 50
Ag/ml gentamicin. Lungs were then photographed using a
Sony CCD-IRIS color video camera attached to an Olympus
microscope. Branching morphogenesis was quantitated
from 0 to 72 h by counting the number of terminal end
buds. Some lung rudiment cultures were done in medium
supplemented in addition to the above, with 2% or 10%
FBS.
E13.5 submandibular gland rudiments were grown on a
porous membrane (5-Am pore size, Nucleopore, Whatman),
supported by a plastic grid and cultured with improved
minimum essential medium (IMEM-ZO) supplemented with
50 Ag/ml transferrin (BD Biosciences). Branching morpho-
genesis was quantitated at 12-, 24-, 48-, and 72-h intervals
by counting the number of terminal end buds.
Gelatin zymography and Western blotting
Lung or submandibular gland tissue from Mmp14/
and +/+ littermate mice was homogenized in cold lysis
buffer (50 mM Tris–HCl pH 7.6, 150 mM NaCl, 5 mM
CaCl2, 10 mM EDTA, and 0.02% Tween), incubated on ice
for 30 min, and centrifuged at 10,000 rpm for 10 min at 48C.
Protein samples (100 Ag) were incubated with 100 Al gelatin
sepharose (Amersham Pharmacia), mixed at 48C for 2 h,
and centrifuged at 8000 rpm for 5 min. Thirty microliters of
the gelatin sepharose beads was electrophoresed on a 10%
SDS–PAGE gel containing 1 mg/ml gelatin (Bio-Rad). The
gel was washed twice (30 min each) with 2.5% Triton X-
100 and then ddH2O, incubated for 48 h in MMP buffer (50
mM Tris–HCl pH 7.4, 200 mM NaCl, 20 mM CaCl2) at
378C, stained with Simply Blue Safestain (Invitrogen) for 1
h, and destained in ddH2O for 8 h, prior to drying using Dry
Ease mini gel drying kit (Invitrogen). For Western blotting,
lung protein extracts were separated by SDS–PAGE and
transferred to a nitrocellulose membrane (BioTracek NT;
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with 10% fat-free dry milk in Tris-buffered saline, the
membrane was probed with anti-laminin-5 g2 chain rat
polyclonal antibody (Pyke et al., 1995) and antibodies to
collagen IV. Anti-actin polyclonal antibody was used as a
control to ensure equal loading. Protein was visualized on
Kodak Biomax chemiluminescent film using ECL Western
Blot Detection reagent (Amersham Pharmacia).
Mouse lung endothelial cells (MLECs) isolation
Lungs from Mmp14/, Mmp14+/, and Mmp14+/+
C57BL/6J mice were excised with sharp scissors,
digested with 0.1% collagenase for 1 h at 378C
(Worthington), and further disaggregated to produce a
single cell suspension. The mixed population obtained
was subjected to negative selection with anti-CD16 (BD
Biosciences)-coated magnetic beads (Dynal) and then to
positive selection with anti-ICAM-2 (BD Biosciences)-
coated magnetic beads, which resulted in a N90% pure
population of endothelial cells. MLECs were grown on a
mixture of 10 mg/ml fibronectin (Sigma), 10 mg/ml
vitrogen (Cohesion), and 0.1% gelatin (Sigma)-coated 75-
cm flasks (Costar Corp.) with DMEM (low glucose),
Ham’s F-12 (Gibco), 20% FBS, heparin (Sigma),
endothelial mitogen (Biogenesis), glutamine (Sigma),
and antibiotics. The cells were used for up to four
passages. MT1-MMP expression was tested in MLEC
lysates by Western blotting with the anti-MT1-MMP
mAb LEM-2/63 (Galvez et al., 2001).
Cell transmigration assay
MLEC transmigration assays were performed in 8-Am
pore transwell chambers (Costar Corp.). Cells were resus-
pended in serum-free medium (Gibco-BEL Life Sciences)
and seeded at 15,000 cells/well on matrigel-coated filters
(Fisher) in the upper chamber. Cells that had migrated onto
the lower surface of the filter were stained with toluidine
blue (Sigma) and counted after 5 h of migration. Experi-
ments were done in duplicate, and four fields of each
transwell were counted with a 40 objective under a
microscope.
In vitro endothelial morphogenesis assay
Matrigel basement membrane matrix (Becton-Dickin-
son) was diluted 1:2 in cold DMEM medium (Gibco).
Diluted Matrigel (80 Al) was plated into flat-bottomed
96-well tissue culture plates (Costar Corp.) and allowed
to gel for 20 min at 378C before cell seeding. Then, 4 
104 cells were added atop the Matrigel. After 4-h
incubation, cord-like and tube-like structures were counted
with a 40 objective microscope in four independent
fields in each well. Experiments were done in duplicate.
Statistical analysis was done using a Student t test for
paired samples.Results
Mmp14/ mice have defective alveolar septal development
Mmp14/ mice were born in the expected mendelian
ratio. Of 52 Mmp14 heterozygote crosses (in the C57/BL6
strain) used in this study, 116 of the progeny (30%) were
homozygous for the wild-type allele, (Mmp14+/+), 178
(45%) were heterozygous (Mmp14+/), and 98 (25%) were
homozygous null (Mmp14/). This approximately 1:2:1
ratio confirms that the null genotype does not cause
embryonic lethality or that it does so very rarely. In
addition, we also bred the null allele into the FVB and
Swiss Webster strains for eight generations and found
anomalies essentially similar to those described here and in
a previous publication (Zhou et al., 2000). The data shown
are all from the C57/BL6 mice.
Because virtually all of our Mmp14/ mice die
between 2 and 3 weeks of age, we initially analyzed their
lungs at 2 weeks. Mmp14+/ lungs were indistinguishable
from those of Mmp14+/+ mice in all aspects of the
morphological findings reported here and are not discussed
further except in the context of studies on endothelial cells.
Lungs from Mmp14/ mice had normal primary branch-
ing, that is, one left lobe and four right lobes, but they were
considerably smaller than those of +/+ (Fig. 1A) or +/
mice at 2 weeks of age, consistent with the overall growth
retardation in these mice. In addition to being smaller,
Mmp14/ lungs had increased peripheral transparency
(Fig. 1A, inset) and showed surface bullae upon inflation,
suggesting hyperinflation of the peripheral air spaces and
attenuation of the parenchymal walls at the pleural surface.
Scanning electron microscopy (SEM) of the lung interior
at 2 weeks of age demonstrated enlarged air saccules in
Mmp14/ lungs (Fig. 1B, right panel). The intervening
walls were thinner in Mmp14/ mice and lacked the
rounded, thick, free edges visible in Mmp14+/+ lungs (Fig.
1B, left panel). The interior of the bronchial tubes visualized
by scanning electron microscopy (SEM) appeared normal,
including the presence of Clara cells (not shown).
Paraffin and plastic-embedded histology, following
fixation under inflation at 2 weeks of age, was consistent
with the SEM observations, showing enlarged air spaces as
well as thinner intervening walls in Mmp14/ mice
(Fig. 1C, right panel). In Mmp14/ mice, air spaces had
smooth walls compared to the normal, irregularly corru-
gated walls of alveoli in Mmp14+/+ mice (Fig. 1C, left
panel). Whereas secondary septae (defined as extensions of
lung parenchyma with free edges) were obvious in
Mmp14+/+ mice, very few were seen in Mmp14/ mice
(Fig. 1C). When present in Mmp14/ mice, secondary
septae were short and triangular in cross-section (Fig. 1C).
The mean linear intercept value, a quantitative measure of
tissue density in the lung, was compared using histological
sections of Mmp14/ and Mmp14+/+ lungs. These
values were 26.87 and 47.65 in Mmp14/ and
Fig. 1. Abnormal morphology of Mmp14/ lungs at 2 weeks of age. (A) Gross appearance shows decreased size of the Mmp14/ lung, as well as
translucency of the periphery (inset higher magnification) hinting at enlarged air spaces. (B) Scanning electron microscopy (1500 magnification). Air spaces
in Mmp14/ mice are dilated with thinner walls between them. Note the rounded edges in Mmp14+/+ lungs and the smaller air spaces of the normal lung.
(C) Light microscopy of toluidine blue-stained, plastic-embedded sections. The arrows indicate septae, and the arrowheads indicate the pleural surface of the
lung. (D) Hematoxylin and eosin (H and E)-stained, paraffin-embedded sections of Mmp14+/+ (left) and Mmp14/ lung (right) from E12.5 to 2 weeks
postnatal (20 magnification). The arrowheads indicate the pleural surface of the lung at E18.5 and 1 week of age. (E) Comparative anatomy of the bronchial
tree of the E18.5 Mmp14+/+ (left) and Mmp14/ (right) mice obtained by three-dimensional reconstruction as explained in Materials and methods. Four
representative blocks from each are illustrated.
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nificant (P = 0.001). The peripheral (subpleural) region of
the lung was thinner in Mmp14/ mice (Fig. 1C, right
panel) and probably explains why bullae were seen on the
surface of the inflated Mmp14/ lung.
To track the developmental chronology of these mor-
phological changes noted at 2 weeks of age, we obtained
histology at earlier postnatal time points (newborn, 2 days
and 1 week, n = 4 each time point). Histological
abnormalities similar to those in 2-week-old lungs were
also consistently present in newborn, 2-day old (not
shown), and 1-week-old Mmp14/ mice (Fig. 1D). Since
secondary septae are formed postnatally, the histological
observations suggested that failure to form secondary
septae and subsequent lack of alveolization were the
principal problems in lung development of Mmp14/
mice.
Mmp14 is expressed during lung embryogenesis but has
a temporally restricted role during late branching
morphogenesis
From embryo (E)12.5 to E15.5 days of development, the
Mmp14/ lungs were histologically indistinguishable
from Mmp14+/+ lungs (Fig. 1D). From E16.5 daysonwards, histological sections showed a relative paucity of
bronchial tubes at the periphery of the lung (Fig. 1D). We
further delineated the structure of the bronchial tree by
three-dimensional reconstruction of tubular structures in the
periphery of the lung at E18.5 days (Fig. 1E) showing
thinner distal bronchioles in Mmp14/ than in the
Mmp14+/+ mice. This suggested a subtle defect in
expansion of peripheral bronchi starting around E16.5.
In situ hybridization demonstrated expression of Mmp14
in bronchial epithelium throughout embryonic lung devel-
opment, as shown, for example, at E14.5 and E17.5
(Fig. 2A). Mmp14 expression was localized to distinct areas
consistent with observations that ECM proteolysis during
branching morphogenesis occurs in a highly regulated
fashion (Wiseman et al., 2003). To elicit the specific role
for MT1-MMP in lung branching morphogenesis, we
isolated E12.5 lung rudiments from Mmp14/ and
Mmp14+/+ mice and cultured them in serum-free medium
for 3 days (Serra et al., 1994), monitoring branching by
counting the end buds. Mmp14+/+ and Mmp14/ lung
explants were indistinguishable at E12.5. After 3 days of
continued development in culture, there was no consistent
morphological difference between Mmp14+/+ and
Mmp14/ lung explants (Fig. 2B). Equal numbers of
end buds were counted in matched pairs of lungs (n = 8)
Fig. 2.Mmp14 is expressed in branching bronchial epithelium, but branching morphogenesis is unaffected in theMmp14/ lung. (A) In situ hybridization of
Mmp14 expression in mouse lung showing lack of sense probe hybridization (left) and hybridization of antisense probe to E14.5 lung (middle panel) and E17.5
lung (right panel). (B) In vitro branching morphogenesis assay starting at E12.5 and terminated after 72 h. The top row shows a representative result obtained
from Mmp14+/+ mice, while the lower row shows development of a lung from an Mmp14/ littermate. (C) End buds were counted every 24 h during the
branching morphogenesis assay for quantitative evaluation of branching morphogenesis. Blue and red lines indicateMmp14+/+ and Mmp14/, respectively.
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branching morphogenesis up to E15.5. To determine
whether acceleration of branching morphogenesis by
addition of serum would uncover a subtle role for MT1-
MMP, we repeated these experiments in the presence of 2%
or 10% fetal bovine serum. No differences were seen
between Mmp14+/+ and Mmp14/ lungs (n = 5), despite
the fact that branching morphogenesis was accelerated in all
explants in the presence of serum (data not shown). Based
on these experiments and histological observations, we
concluded that, although it is expressed in bronchial
epithelium, Mmp14 has a largely redundant role in lung
development between E12.5 and E15.5, being required for atemporally specific, relatively minor role in distal bronchio-
lar expansion after E16.5.
Normal extracellular matrix and cell differentiation in
Mmp14/ lungs
Since one of the demonstrated functions for MT1-MMP is
remodeling of the extracellular matrix, we used transmission
electron microscopy (TEM) to examine the basement
membranes at the gas–blood interface and the cellular
composition of the pulmonary parenchyma at 2 weeks of
age. The basement membrane at the gas–blood exchange
surface was of comparable thickness in Mmp14+/+ and
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could be visualized in Mmp14+/+ and Mmp14/ mice
(Fig. 3B). Type II cells in the Mmp14/ mice contained
lamellar bodies and demonstrated extrusion of their contents
(surfactant) at the cell surface as in theMmp14+/+ mice. The
developing septae inMmp14/ mice were blunted, but like
those of Mmp14+/+ mice, they contained a capillary as well
as an elastic fiber at the tip (Fig. 3C).Fig. 3. Ultrastructural comparison of 2-week-old Mmp14/ and +/+ lungs. (A
basement membrane; E, erythrocyte (15,000 magnification). (B) Representative
Mmp14+/+ and Mmp14/ mice (8750 magnification). Capillaries occupied
Mmp14+/+ mouse (left) is compared to two septae fromMmp14/ mice. CapillaBoth TEM (Fig. 3C) and modified Hart’s stain (Fig. 4A)
showed elastin to be present in developing septae, alveolar
walls, and the pleural surface of the lung (Fig. 4A).
Quantitative comparison of desmosine cross-links in paired
littermates as an indicator of elastin content provided
values of 318 F 121 pM desmosine/mg of total protein in
Mmp14+/+ mice (n = 5) and 262 F 35 pM desmosine/mg
of total protein in Mmp14/ littermates (n = 5). A paired) Basement membrane at the air–capillary interface. P, pneumocyte; BM,
transmission electron micrographs are shown from the lung parenchyma of
by erythrocytes are indicated (c). (C) A typical alveolar septum from an
ries occupied by erythrocytes (c) and terminal elastic fibers (e) are indicated.
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lower desmosine content, the difference was not sta-
tistically significant. Western blot analysis of collagen I,
collagen IV (a3 chain), and collagen IV (a5 chain) content
showed no differences betweenMmp14/ andMmp14+/+
lungs (data not shown). Immunostaining of basement
membrane (collagen IV; Fig. 4B) revealed no significantdifferences. In order to examine differentiation of the surface
epithelium of the lung throughout development, we carried
out in situ hybridization for the detection of surfactant
protein C mRNA (Spc), a type II epithelial cell marker. Spc
expression patterns were comparable in normal and mutant
lungs from E14.5 through postnatal development (shown
in E; 16.5 days and 2 days of age in Fig. 4C), suggesting
that differentiation of alveolar surface epithelium pro-
ceeded normally in Mmp14/ mice. Immunostaining for
markers of bronchial epithelium (Clara cell secreted
protein/CCSP; data not shown) gave essentially similar
results in Mmp14/ and Mmp14+/+ lungs. Markers for
blood vessels [von Willebrand factor (vWF), Fig. 4D] and
capillaries (CD31/PECAM-1) did not demonstrate differ-
ences between Mmp14/ and Mmp14+/+ lungs. Due
to the very different architecture of Mmp14/ and
Mmp14+/+ lungs and because capillaries run continuously
throughout the alveolar walls, we did not quantitate CD31
staining; however, capillaries were clearly present in all
alveolar walls and septae of the null mice (see also TEM
data, Fig. 3). Immunostaining with smooth muscle a-actin
demonstrated positively stained cells in the distal airspaces
of Mmp14/ null mice, including the septae, indicative of
the presence of myofibroblasts (Fig. 4E).
The laminin-5 g2 chain is a substrate for both MMP-2
and MT1-MMP, and its proteolysis promotes cell migration
(Giannelli et al., 1997). Since proteolysis of the laminin-5
g2 chain was reportedly reduced in kidney and lung
basement membranes of Mmp14/ mice (Koshikawa et
al., 2004), we used an anti-laminin-5 g2 chain antibody
(Pyke et al., 1995) for Western blots of whole lung extract at
two different ages (Fig. 4F). No alteration of laminin-5 g2
chain processing was seen.
MT1-MMP is present on mouse lung endothelial cells and is
required for migration and the formation of tube-like
structures on matrigel
Mouse lung endothelial cells (MLEC) were isolated from
Mmp14+/+,Mmp14+/, andMmp14/ mice. First, MT1-
MMP expression in these cells was analyzed by Western
blotting with an anti-MT1-MMP monoclonal antibody,
LEM-2/63, which recognizes the mouse protein (Galvez et
al., 2001). MT1-MMP was present in MLECs fromFig. 4. Comparative analysis of Mmp14+/+ (left) and Mmp14/ (right)
mice. (A) Hart’s stain for elastin with arrows indicating elastic fibers in septae
of 2-week-old lungs. (B) Collagen IV immunohistochemistry. Septae are
indicated by arrows. (C) In situ hybridization of the surfactant protein C
(Spc) gene in E16.5 and 2-day-old (P2) mice. (D) von Willebrand factor
immunostaining showing mature blood vessels in 2-week-old lungs. (E)
Smooth muscle a-actin stain for myofibroblasts (indicated in septal tip by
arrows). (F) Western blot analysis of the laminin-5 g2 chain using lung
extracts. The age of mice and their genotype are indicated above the blot.
Molecular mass markers are shown at left. The proteolytically derived
fragments of laminin-5 g2, g2V, and g2x are shown at right. AWestern blot for
a-actin is shown in the box at the bottom of the figure to indicate protein
loading to each lane.
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latter) but was not present in MLECs fromMmp14/ mice
(Fig. 5A). The role of MT1-MMP in endothelial cell
migration was next studied in a transwell chamber assay
(Galvez et al., 2001). Spontaneous transmigration of MLECs
through matrigel-coated filters was consistently decreased in
the cells lacking MT1-MMP (Fig. 5B). Interestingly, with
MLEC from Mmp14+/ mice, the reduction was quantita-
tively reduced to approximately half that of the wild type
(Fig. 5B). The process of formation of three-dimensional
structures by null MLECs was analyzed using an in vitroFig. 5. Mmp14 is required for mouse endothelial cell migration and tube
formation. (A) MLEC from littermates were lysed in Laemmli sample
buffer and analyzed by Western blot using anti-MT1-MMP antibody LEM-
2/63. Note that Mmp14/ MLEC did not express MT1-MMP. (B) MLEC
from Mmp14+/+, Mmp14+/, and Mmp14/ mice were grown on
Matrigel-coated 8-Am pore filters and allowed to migrate in transwell assays
for 5 h. The number of cells migrating to the lower chamber was quantitated
as described. (C) MLEC from Mmp14+/+, Mmp14+/, and Mmp14/
mice were seeded on Matrigel, and the number of cord or tube-like
structures formed was quantitated after 4 h.assay on matrigel. The spontaneous formation of cord-like or
tube-like structures fromMLECswas considerably decreased
in cells lacking MT1-MMP, as well as to a lesser degree in
MLECs from Mmp14+/ mice (Fig. 5C).
Mmp14/ mice have defective submandibular gland
branching morphogenesis
In situ hybridization showed prominent Mmp14 expres-
sion in the epithelial cells of the developing submandibular
gland (Fig. 6A). Two-week-old submandibular glands from
Mmp14/ mice were smaller than their control littermates
and consistently demonstrated smaller lobules (Fig. 6B). In
order to determine if submandibular gland branching
morphogenesis was defective, an in vitro assay (Durbeej et
al., 2001) using E13.5 submandibular gland rudiments was
undertaken. At the time of dissection, each rudiment had
three branch buds. Starting as early as 12 h after initiation of
organ culture and throughout the subsequent period in
culture, the Mmp14/ submandibular glands were smaller
in size and had fewer end buds (Figs. 6C, D). By 72 h, the
number of end buds formed in Mmp14/ submandibular
glands was fewer than in theirMmp14+/+ littermate controls
(n = 5) indicating subnormal branching (Figs. 6C, D). In
addition to having fewer end buds, the mutant submandib-
ular gland end buds also appeared dilated (Fig. 6C).
Defective activation of pro-MMP-2 is seen during lung
development in Mmp14/ mice, but lung and
submandibular gland development is normal in
Mmp2/ mice
Since MT1-MMP has a role in activation of MMP-2, we
analyzed MMP-2 forms in the embryonic and postnatal lung.
Gelatin zymography of Mmp14/ lungs at various
developmental stages showed decreased activation of pro-
MMP-2 in E16.5, 1-week-old, and 2-week-old lungs
(Fig. 7A), but no changes in the levels or activation status
of pro-MMP-9 (data not shown). However, some active
MMP-2 enzyme was seen in embryonic Mmp14/ lungs,
suggesting that other activation mechanisms were compen-
sating for the lack of MT1-MMP in Mmp14/ lungs (Fig.
7A). We next asked whether this failure to activate pro-
MMP-2 mediated the postnatal abnormalities seen in
Mmp14/ lungs. We analyzed the histology of 2-week-
old Mmp2/ mice (n = 12) relative to their +/+ littermates
(n = 12) and found that they neither had anomalies similar to
those in Mmp14/ mice, nor did they appear abnormal in
any other way (Figs. 7B, C). In Mmp2/ mice, secondary
septae were present and as developed as in the Mmp2+/+
mice. Again, to determine whether the submandibular gland
changes were a consequence of defective pro-MMP-2
activation, we obtained gelatin zymograms from the sub-
mandibular gland, which showed decreased MMP-2 activa-
tion at E18.5 days of development but little activation at
other time points in both Mmp14/ and Mmp14+/+ mice
Fig. 6. Defective branching morphogenesis in Mmp14/ submandibular gland rudiments. (A) Nonisotopic in situ hybridization of an E17.5 submandibular
gland showing specific hybridization to ductal/glandular epithelium (magenta-stained cells). (B) Comparative H and E stained histology of 2-week-old
Mmp14+/+ (left panel) and Mmp14/ (right panel) submandibular gland. (C) Representative organ culture of submandibular glands from Mmp14+/+ (top
row) and Mmp14/ mice (lower row) over a period of 72-h culture in serum-free medium. (D) End buds were counted during the branching morphogenesis
assay. Blue and red lines indicate Mmp14+/+ and Mmp14/, respectively.
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submandibular glands did not show any anomalies (Fig. 7E).Discussion
Consistent with early studies showing that MT1-MMP is
a collagenase that is prominently expressed in connective
tissue cells such as osteoblasts, osteoclasts, and perichon-
drial, muscle, and tendon fibroblasts (Apte et al., 1997;
Kinoh et al., 1996), Mmp14/ mice generated independ-
ently by two groups had a strikingly abnormal musculoske-
letal system (Holmbeck et al., 1999; Zhou et al., 2000). The
present studies show that Mmp14 is also expressed inepithelial organs such as the lung and submandibular gland,
although the levels of expression appear lower than in
developing connective tissue by in situ hybridization. Very
few MMPs or their inhibitors the TIMPs are developmen-
tally expressed in epithelia. Matrilysin-1 (MMP-7) is an
exception (Dunsmore et al., 1998), but Mmp7 null mice are
developmentally normal. Instead, MMP-7 appears to regu-
late innate immunity (Wilson et al., 1999). Timp3 is very
highly expressed in developing lung and salivary gland
epithelium (Apte et al., 1994), and Timp3 null mice have
developmental lung anomalies including defective branch-
ing morphogenesis (Gill et al., 2003; Leco et al., 2001).
However, since TIMP-3 inhibits members of the MMP,
ADAM, and ADAMTS protease families (Amour et al.,
Fig. 7. MT1-MMP has a role in pro-MMP-2 activation, butMmp2/ mice do not have lung and submandibular gland anomalies. (A) Gelatin zymography of
lung extracts fromMmp14+/+ andMmp14/ mice. Molecular identities of gelatinase activities are shown on the left, and the origin of each sample is shown
above the corresponding lane. The data are representative of that obtained from three pairs of lungs at each age. (B, C) Comparative H and E-stained histology
of Mmp2+/+ lungs (left panels) with Mmp2/ lungs (right panels) at 2 weeks of age (B) and in newborn mice (C). (D) Gelatin zymography of
submandibular glands from Mmp14+/+ and Mmp14/ mice. Little activation was seen other than at E18.5 in Mmp14+/+ mice. (E) Comparative H and E-
stained histology of 2-week-old Mmp2+/+ salivary gland (left panel) with Mmp2/ submandibular gland (right panel).
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difficult to implicate specific proteases in the genesis of this
phenotype. Thus, although a variety of studies have
implicated metalloproteases in branching of epithelia,
genetic evidence implicating specific MMPs has been
scarce. Recently, a comprehensive study that utilized
Mmp2 and Mmp3 null mice demonstrated that MMP-2
and MMP-3, both of which are stromally expressed,
regulated postpubertal mammary gland development (Wise-
man et al., 2003). However, neither was essential for
prepubertal mammary development.
To evaluate the significance of Mmp14 expression in
lung and submandibular gland, we investigated the develop-
ment of these organs in Mmp14/ mice. The lung
presents a very complex developmental scenario in whichintegrated bronchial and vascular morphogenesis is required
for gas–blood exchange, whereas the submandibular gland
represents a simple secretory acinar gland. Since the
Mmp14/ mice used in this study die between 2 and 3
weeks of age (Zhou et al., 2000), we initially carried out a
detailed morphological analysis at 2 weeks of age, compar-
ing Mmp14/ mice with their wild-type and heterozygous
littermates. The histological appearance of the lung from the
Mmp14/ mice resembled that seen in emphysema, with
large air spaces and thin, stretched alveolar walls. However,
since the anomaly was visible at birth and was unaccompa-
nied by an inflammatory process, it suggested a devel-
opmental, not acquired, origin.
Mouse lung development commences around E9.5 with
the outgrowth of a tracheal diverticulum from the primitive
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tion and further division to the primary lobar bronchi, which
appears to be genetically bhard-wired,Q successive hierarch-
ical branching occurs, so that a pseudoglandular structure is
manifest at E12 (E9.5–16.5, the pseudoglandular stage). In
the canalicular stage (E16.5–17.5), terminal sac formation
and vascularization are initiated. During the terminal sac
stage [E17.5 postnatal day (P)5], the number of terminal sacs
increases. From P5 to P30, terminal sacs develop into mature
alveoli (Warburton et al., 2000). Despite specific bronchial
expression ofMmp14 in the pseudoglandular stage, we found
no defect in branching morphogenesis between 12.5 and 15.5
days of gestation using a well-characterized in vitro branch-
ing assay (Ganser et al., 1991; Serra et al., 1994; Weaver and
Hogan, 2000). However, subtle morphological anomalies
were seen later in embryonic development, suggesting a
temporally restricted role for MT1-MMP starting in the
canalicular stage and coincident with the initial stages of
integration of pulmonary vasculature and branching epithe-
lium (Warburton et al., 2000). Except for this, we concluded
that MT1-MMP has a largely redundant role in branching
morphogenesis of lung. In the salivary gland, however, MT1-
MMP requirement was more stringent than in the lung since
we noted abnormal branching in in vitro assays.
In mice, as in other mammals, including humans, lung
development is incomplete at birth. The immature (pre-
alveolar) saccules present at birth are further divided into
alveoli (alveolization) by the formation and growth of septae
from the saccular walls. This serves to substantially increase
the surface area of the gas–blood interface. Alveolization
commences shortly after birth and continues up to 30 days
postnatally in mice (Warburton et al., 2000). A variety of
morphological techniques led us to conclude that the
principal defect in Mmp14/ mice was a combined failure
of postnatal saccular development and failure of secondary
septae to form and extend fully into the prealveolar saccules,
leading to defective alveolization. The hyperinflation of
immature saccules and stretching of their walls, giving rise
to a pseudoemphysematous appearance, likely represents an
adaptive response.
MT1-MMP has been studied most extensively in the
context of cell-surface activation of pro-MMP-2 and pro-
MMP-13, and recent evidence suggests that Mmp2/
mice have defective angiogenesis (Itoh et al., 1998) and
impaired postpubertal mammary gland ductal development
(Wiseman et al., 2003). Pro-MMP-2 activation requires
TIMP-2 as an intermediary, and the essential role of TIMP-2
is underscored by the exquisite coregulation of Mmp14 and
Timp2 in musculoskeletal tissues (Apte et al., 1997) and the
lack of pro-MMP-2 activation in Timp2 null mice (Wang et
al., 2000). Accordingly, we examined the expression of
Timp2 and found it to be coexpressed with Mmp14 in lung
and salivary gland (data not shown). Furthermore, gelatin
zymograms of lungs and salivary gland from Mmp14/
mice suggested a role for MT1-MMP in pro-MMP-2
processing and that it was a possible mechanism for theanomalies we noted in these mice. Nevertheless, a com-
parable appearance of lung and salivary gland of Mmp2/
mice to that seen in the Mmp14/ mice was not seen. All
lungs were carefully fixed under inflation to provide
standardized histology. Both Mmp14/ and Mmp2/
mice are in a C57/BL6 background, thus eliminating strain
differences. We have also considered the possibility that the
Mmp2/ mice may have an incompletely penetrant lung
phenotype, since a previous study had suggested abnormal
alveolization in a small number (15%) of Mmp2/ mice
(Kheradmand et al., 2002). Our studies suggest, however,
that mice are born in the expected mendelian ratio, that is,
without loss of a small number of mice with a severe lung
phenotype. Since gelatin zymography of the Mmp2/
mice showed no detectable MMP-2 activity (data not
shown), Mmp14/ mice would not in fact have as severe
a deficiency of active MMP-2 as the Mmp2/ mice.
We therefore concluded that the partial loss of pro-MMP-
2 activation seen in Mmp14 null mice is not the underlying
mechanism for the abnormalities seen in the lung and
salivary gland. MT1-MMP has also been implicated in
activation of the collagenase pro-MMP-13 (Knauper et al.,
2002). However, unpublished studies of Mmp13/ mice
(personal communication of Dr. Stephen Krane, Massachu-
setts General Hospital) indicate that they do not have
abnormal pulmonary histology.
What then could be responsible for defective alveoliza-
tion in Mmp14/ mice? The data summarized in Table 1
suggest no significant molecular differences between
Mmp14/ and Mmp14+/+ mice. Neither accumulation
of interstitial collagen nor thickening of basement mem-
brane was seen by TEM or immunohistochemistry. In
addition, laminin-5 processing was unaffected, suggesting
that failure of collagen I or basement membrane proteolysis
did not underlie the phenotype. We detected normal cell
differentiation in the Mmp14/ mice. There was a well-
defined elastin network throughout the lung. Thus, although
the phenotype was somewhat similar to that of elastin-
deficient mice (Wendel et al., 2000), deficient elastogenesis
did not explain the anomalies. We also considered that
defective release or activation of ECM-bound growth
factors could give rise to the anomalies noted. Although
Egfr/ mice have defective alveolization (Miettinen et al.,
1995), they also have defective branching morphogenesis in
lung explants (Miettinen et al., 1997), which was not seen in
Mmp14/ mice. Pdgfa/ mice have a pseudo-emphy-
sematous phenotype that superficially resembles that of the
Mmp14/ mice and is caused by failed septation
(Bostrom et al., 1996). PDGF-A is essential for myofibro-
blast development, and these cells are absent in Pdgfa/
lungs (Bostrom et al., 1996). However, smooth muscle a-
actin-positive cells (presumed myofibroblasts) were clearly
present in 2-week-old Mmp14/ mice, including a cell
consistently present at the tip of the septum.
Two substantive considerations led us to investigate
defective angiogenesis as an underlying mechanism of the
Table 1
Comparison of molecular parameters evaluated in the lungs of 2-week-old
Mmp14+/+ and Mmp14/ mice
Target Assay Outcome
Collagen I Immunoblot Identical bands
of similar intensity
Collagen IV a3 Immunoblot Identical bands
of similar intensity
Collagen IV a5 Immunoblot Identical bands
of similar intensity
Laminin-5 g2 Immunoblot Identical bands
of similar intensity





Collagen IV Immunohistochemistry Similar distribution
and intensity
PECAM-1/CD31 Immunohistochemistry Similar distribution
and intensity
Surfactant protein B Immunohistochemistry Similar distribution
and intensity
von Willebrand factor Immunohistochemistry Similar distribution
and intensity
Elastin Modified Hart’s stain Similar distribution
and intensitya
a Owing to the stretched alveolar wall in Mmp14/ mice, elastic fibers
appeared to be attenuated but were present in all septae.
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angiogenesis in septation and the second related to the
emerging role for MT1-MMP in diverse aspects of angio-
genesis. Early morphological studies demonstrated the
intimate involvement of a new capillary loop in pulmonary
septal growth (Burri, 1974, 1984). Recent experimental work
showed that the anti-angiogenic agents, fumagillin and
thalidomide, and a chemical inhibitor of the vascular
endothelial growth factor (VEGF) receptor (Su-5416)
reduced alveolization in rats during the first 2 weeks of life
(Jakkula et al., 2000; Kasahara et al., 2000). Administration
of mFlt(1-3)-IgG (a soluble VEGF receptor that acts as a
decoy for the circulating VEGF) shortly after birth resulted
in severe dwarfism and anomalies in multiple epithelial
organs such as liver, kidney, and lung (Gerber et al., 1999).
The lungs in mFlt(1-3)-IgG-treated mice appear histologi-
cally similar to those of Mmp14/ mice showing large air
saccules and poor septal growth (Gerber et al., 1999).
MT1-MMP has a compelling connection with angio-
genesis. Transcriptional upregulation of MT1-MMP occurs
as an Egr-1-mediated early event during the initial stages of
formation of three-dimensional structures and capillary
tubes from microvascular endothelial cells (Haas et al.,
1998, 1999). The significance of this may not be related to
ECM proteolysis alone, since it has been demonstrated that
MT1-MMP upregulates VEGF expression in endothelial
cells (Sounni et al., 2002, 2004), although the underlying
mechanisms are unclear. Previous characterization of the
Mmp14/ mice demonstrated impaired vascular invasion
of some primary and secondary centers of ossification in the
developing skeleton (Holmbeck et al., 1999; Zhou et al.,2000). In addition, we had used a corneal neovascularization
assay to demonstrate the lack of an angiogenic response to
FGF-2 in Mmp14/ mice (Zhou et al., 2000). It is also
noteworthy that the emergence of lung anomalies in
Mmp14/ mice occurred coincidentally with the initial
vascularization of the lung (around E16.5) (Warburton et al.,
2000).
Accordingly, we asked if MLECs from Mmp14/ mice
at 1 week of age behaved differently from those isolated
from wild-type Mmp14 littermates. Our studies show that
MLECs not only express MT1-MMP, but that those from
Mmp14/ mice are indeed defective in cell migration and
tube formation, two of the essential prerequisites for angio-
genesis. PECAM/CD31 stained cells were seen in all
alveolar walls, as expected, and capillaries were seen on
TEM throughout the lung and in each septum. We suggest
that impairment of migration and tube formation restricts
their ability to grow further into the developing septum
postnatally and is rate-limiting for further lung development.
A reduction of angiogenic potential in Mmp14+/ mice is
plausible but did not affect normal development, since these
mice (and their lungs) were indistinguishable from the wild-
type mice. Until selective targeted deletion of Mmp14 in
endothelial cells is achieved, it will not be possible to
evaluate whether impaired angiogenesis is the only mecha-
nism underlying defective alveolization. For instance, we
note that myofibroblasts are present in the lungs of
Mmp14/ mice, but we have not excluded possibility that
their migration might also be defective.
In conclusion, the data presented here support a
significant role for MT1-MMP in morphogenesis of
epithelial tissues through studies of two representative
organs. The contrasting roles in each are evident from the
postnatal defect in lung development with normal branching
morphogenesis, whereas the defect in submandibular gland
development is embryological and affects branching mor-
phogenesis. Despite these differences, our studies make the
important point that the underlying mechanisms are
independent of pro-MMP-2 activation and, at least in the
lung, may involve a restriction of angiogenesis. The data
support an emerging model in which angiogenesis is
essential for the growth and maintenance of pulmonary
parenchymal mass (Gerber et al., 1999; Jakkula et al., 2000;
Kasahara et al., 2000; Shapiro, 2000; Tuder et al., 2000,
2003). We propose that the bemphysema-likeQ morphology
of Mmp14/ lungs represents an arrest of postnatal lung
development and is the maximal parenchymal mass that can
be attained and supported in the presence of reduced
endothelial capillary-forming ability.Acknowledgments
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